Search Results - "LaCroix, Bonnie L."

A prospective trial of abiraterone acetate plus prednisone in Black and White men with metastatic castrate‐resistant prostate cancer by George, Daniel J., Halabi, Susan, Heath, Elisabeth I., Sartor, A. Oliver, Sonpavde, Guru P., Das, Devika, Bitting, Rhonda L., Berry, William, Healy, Patrick, Anand, Monika, Winters, Carol, Riggan, Colleen, Kephart, Julie, Wilder, Rhonda, Shobe, Kellie, Rasmussen, Julia, Milowsky, Matthew I., Fleming, Mark T., Bearden, James, Goodman, Michael, Zhang, Tian, Harrison, Michael R., McNamara, Megan, Zhang, Dadong, LaCroix, Bonnie L., Kittles, Rick A., Patierno, Brendon M., Sibley, Alexander B., Patierno, Steven R., Owzar, Kouros, Hyslop, Terry, Freedman, Jennifer A., Armstrong, Andrew J.

“…Background Retrospective analyses of randomized trials suggest that Black men with metastatic castration‐resistant prostate cancer (mCRPC) have longer survival…”
Get full text

Abstract D064: Race-related RNA splicing dysregulation of PI3Kd signaling: A therapeutic target for aggressive prostate cancer by LaCroix, Bonnie L, George, Daniel J, Freedman, Jennifer A, Patierno, Steven R

“…Abstract Background: Age-adjusted incidence and mortality rates for prostate cancer (PCa) among African Americans (AAs) are greater than among whites. The more…”
Get full text

Abstract PO-128: Interrogating the role of race-related alternative splicing of SEMA3C in prostate cancer by Allen, Tyler A., Chandar, Jay, Lacroix, Bonnie L., Patierno, Steven R., George, Daniel J., Freedman, Jennifer A.

“…Abstract The age-adjusted incidence and mortality rates for prostate cancer (PCa) among African American (AA) men are 1.6- and 2.4-fold greater, respectively,…”
Get full text

Abstract B006: Development of a novel therapeutic splice-switching oligonucleotide targeting race-related androgen receptor signaling and aggressive prostate cancer by LaCroix, Bonnie L., Patierno, Brendon M., Sullenger, Bruce A., George, Daniel J., Patierno, Steven R., Freedman, Jennifer A.

“…Abstract Background: Age-adjusted incidence and mortality rates for prostate cancer (PCa) among African American (AA) men are 1.6- and 2.4-fold greater,…”
Get full text

Abstract PR04: Development of a novel therapeutic splice-switching oligonucleotide targeting race-related androgen receptor signaling and aggressive prostate cancer by LaCroix, Bonnie L., Patierno, Brendon M., Sullenger, Bruce A., George, Daniel J., Patierno, Steven R., Freedman, Jennifer A.

“…Abstract Background: Age-adjusted incidence and mortality rates for prostate cancer (PCa) among African American (AA) men are 1.6- and 2.4-fold greater,…”
Get full text

Abstract PO-100: Ancestry-related variation in Sphingosine Kinase Type 1-Interacting Protein (SKIP) and Sphingosine Kinase 1 (SPHK1) and response to secondary hormonal therapy in metastatic castration-resistant prostate cancer by Piwarski, Sean A., Allen, Tyler A., Zhang, Dadong, Sibley, Alexander B., Healy, Patrick, Patierno, Brendon M., LaCroix, Bonnie L., Kittles, Rick A., Owzar, Kouros, Hyslop, Terry, Patierno, Steven R., George, Daniel J., Freedman, Jennifer A.

“…Abstract The number of cases and deaths from prostate cancer (PCa) is highest for African American (AA) men compared with men of other racial and ethnic…”
Get full text